REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Clinical trial NCT07160231 · RECRUITING

Trial details

NCT number: NCT07160231
Sponsor: Sint Maartenskliniek
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)

Start date: 2025-09-15
Primary completion: 2028-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.